Clinical Trial AdvancementThe Phase 1/2 multi-center trial in knee osteoarthritis includes a double-blind, randomized, placebo-controlled stage, demonstrating a rigorous approach to evaluating treatment efficacy.
Potential Market OpportunityEnlivex is planning a follow-on study in UTI-related sepsis, targeting a significant market opportunity in a field with high unmet medical need and lack of effective FDA-approved treatments.
Regulatory MilestoneThe Danish Medicines Agency has granted authorization for the expansion of the knee osteoarthritis clinical trial program, signaling a broader international research effort.